{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:09:55Z","timestamp":1770970195407,"version":"3.50.1"},"reference-count":75,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2021,1,1]]},"DOI":"10.1001\/jamapsychiatry.2020.2762","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T18:09:10Z","timestamp":1599070150000},"page":"91","source":"Crossref","is-referenced-by-count":30,"title":["Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents"],"prefix":"10.1001","volume":"78","author":[{"given":"Jenny W.","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Hern\u00e1ndez-D\u00edaz","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Haneuse","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence T.","family":"Bourgeois","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seanna M.","family":"Vine","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Olfson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian T.","family":"Bateman","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista F.","family":"Huybrechts","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"9","key":"yoi200053r1","first-page":"26","article-title":"Antidepressants for pediatric patients.","volume":"18","author":"Dwyer","year":"2019","journal-title":"Curr Psychiatr"},{"key":"yoi200053r2","article-title":"Antidepressant tolerability in pediatric anxiety and obsessive-compulsive disorders: a Bayesian hierarchical modeling meta-analysis.","author":"Mills","year":"2019","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"yoi200053r3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40272-015-0153-1","article-title":"Pharmacotherapy for pediatric generalized anxiety disorder: a systematic evaluation of efficacy, safety and tolerability.","volume":"18","author":"Dobson","year":"2016","journal-title":"Paediatr Drugs"},{"issue":"9","key":"yoi200053r4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/pds.4240","article-title":"Trends in antidepressant prescribing to children and adolescents in Canadian primary care: a time-series analysis.","volume":"26","author":"Morkem","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"21","key":"yoi200053r5","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1056\/NEJMsa1413512","article-title":"Trends in mental health care among children and adolescents.","volume":"372","author":"Olfson","year":"2015","journal-title":"N Engl J Med"},{"key":"yoi200053r6","author":"Ghandour","year":"2019","journal-title":"J Pediatr"},{"issue":"6","key":"yoi200053r7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1878","article-title":"National trends in the prevalence and treatment of depression in adolescents and young adults.","volume":"138","author":"Mojtabai","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"yoi200053r8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.euroneuro.2016.02.001","article-title":"Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012.","volume":"26","author":"Bachmann","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"yoi200053r9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/da.2015.32.issue-3","article-title":"Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.","volume":"32","author":"Strawn","year":"2015","journal-title":"Depress Anxiety"},{"issue":"5","key":"yoi200053r10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1176\/appi.ajp.2017.16091059","article-title":"Antidepressant efficacy for depression in children and adolescents: industry- and NIMH-funded studies.","volume":"174","author":"Walkup","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"5","key":"yoi200053r11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1176\/appi.ajp.2008.08071065","article-title":"Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.","volume":"166","author":"Andersohn","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"1","key":"yoi200053r12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00125-011-2268-4","article-title":"Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults.","volume":"55","author":"Pan","year":"2012","journal-title":"Diabetologia"},{"issue":"7","key":"yoi200053r13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182088","article-title":"The risk of new-onset diabetes in antidepressant users: a systematic review and meta-analysis.","volume":"12","author":"Salvi","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"yoi200053r14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/dmrr.v29.4","article-title":"Antidepressant use and new-onset diabetes: a systematic review and meta-analysis.","volume":"29","author":"Bhattacharjee","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"yoi200053r15","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2337\/dc07-1827","article-title":"Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.","volume":"31","author":"Rubin","year":"2008","journal-title":"Diabetes Care"},{"issue":"12","key":"yoi200053r16","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.2337\/dc10-1187","article-title":"Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study.","volume":"33","author":"Kivim\u00e4ki","year":"2010","journal-title":"Diabetes Care"},{"issue":"8","key":"yoi200053r17","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.2337\/dc13-2642","article-title":"Depressive symptoms, antidepressant use, and the incidence of diabetes in the Black Women\u2019s Health Study.","volume":"37","author":"Vimalananda","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"yoi200053r18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.diabres.2007.07.009","article-title":"Type of antidepressant therapy and risk of type 2 diabetes in people with depression.","volume":"79","author":"Brown","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"yoi200053r19","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.biopsych.2011.07.008","article-title":"Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association?","volume":"70","author":"Kivim\u00e4ki","year":"2011","journal-title":"Biol Psychiatry"},{"issue":"3","key":"yoi200053r20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1037\/a0029014","article-title":"Is ignorance bliss? depression, antidepressants, and the diagnosis of prediabetes and type 2 diabetes.","volume":"32","author":"Mezuk","year":"2013","journal-title":"Health Psychol"},{"issue":"6","key":"yoi200053r21","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/ije\/dyv153","article-title":"Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, \u00df-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort.","volume":"44","author":"Azevedo Da Silva","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"12","key":"yoi200053r22","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.2337\/dc11-0107","article-title":"Depressive symptoms, antidepressant medication use, and insulin resistance: the PPP-Botnia Study.","volume":"34","author":"Pyykk\u00f6nen","year":"2011","journal-title":"Diabetes Care"},{"issue":"4","key":"yoi200053r23","doi-asserted-by":"crossref","DOI":"10.3390\/jcm5040048","article-title":"Long-term weight change after initiating second-generation antidepressants.","volume":"5","author":"Arterburn","year":"2016","journal-title":"J Clin Med"},{"issue":"8","key":"yoi200053r24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1001\/jamapsychiatry.2014.414","article-title":"An electronic health records study of long-term weight gain following antidepressant use.","volume":"71","author":"Blumenthal","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"yoi200053r25","doi-asserted-by":"publisher","first-page":"k1951","DOI":"10.1136\/bmj.k1951","article-title":"Antidepressant utilisation and incidence of weight gain during 10 years\u2019 follow-up: population based cohort study.","volume":"361","author":"Gafoor","year":"2018","journal-title":"BMJ"},{"issue":"12","key":"yoi200053r26","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jamapediatrics.2017.2896","article-title":"Association of antidepressant medications with incident type 2 diabetes among Medicaid-insured youths.","volume":"171","author":"Burcu","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"8","key":"yoi200053r27","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jaac.2017.04.004","article-title":"Concomitant use of atypical antipsychotics with other psychotropic medication classes and the risk of type 2 diabetes mellitus.","volume":"56","author":"Burcu","year":"2017","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"yoi200053r28","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jamapediatrics.2018.1005","article-title":"Mental disorders, antidepressants, and type 2 diabetes.","volume":"172","author":"Mansur","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"4","key":"yoi200053r29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/aje\/kwv149","article-title":"Depressive symptoms during adolescence and young adulthood and the development of type 2 diabetes mellitus.","volume":"183","author":"Suglia","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"11","key":"yoi200053r30","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.2337\/dc11-1131","article-title":"Longitudinal study of depressive symptoms and progression of insulin resistance in youth at risk for adult obesity.","volume":"34","author":"Shomaker","year":"2011","journal-title":"Diabetes Care"},{"issue":"9575","key":"yoi200053r31","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/S0140-6736(07)60821-6","article-title":"Acute and chronic complications of type 2 diabetes mellitus in children and adolescents.","volume":"369","author":"Pinhas-Hamiel","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"yoi200053r32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1542\/peds.2013-3225","article-title":"Pediatric drug formulations: a review of challenges and progress.","volume":"134","author":"Ivanovska","year":"2014","journal-title":"Pediatrics"},{"issue":"23","key":"yoi200053r33","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMp1802197","article-title":"Assessing drug safety in children\u2014the role of real-world data.","volume":"378","author":"McMahon","year":"2018","journal-title":"N Engl J Med"},{"issue":"15","key":"yoi200053r34","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1056\/NEJM200010123431515","article-title":"Unapproved and off-label use of drugs in a children\u2019s hospital.","volume":"343","author":"\u2019t Jong","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"yoi200053r35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1542\/peds.2013-4060","article-title":"Off-label use of drugs in children.","volume":"133","author":"Frattarelli","year":"2014","journal-title":"Pediatrics"},{"issue":"4","key":"yoi200053r36","first-page":"316","article-title":"Unlicensed and off-label drug use in children before and after pediatric governmental initiatives.","volume":"20","author":"Corny","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"5","key":"yoi200053r37","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s11096-018-0717-6","article-title":"Filled prescriptions of age-related contraindicated drugs in children: a one-year nationwide cohort study in the Netherlands.","volume":"40","author":"Cheung","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"yoi200053r38","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0896","article-title":"Trends in off-label drug use in ambulatory settings: 2006-2015.","volume":"144","author":"Hoon","year":"2019","journal-title":"Pediatrics"},{"issue":"4","key":"yoi200053r39","doi-asserted-by":"publisher","first-page":"e821","DOI":"10.1542\/peds.2015-2092","article-title":"Trends in emergency department visits for unsupervised pediatric medication exposures, 2004-2013.","volume":"136","author":"Lovegrove","year":"2015","journal-title":"Pediatrics"},{"issue":"13","key":"yoi200053r40","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2165\/00002018-200427130-00006","article-title":"The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.","volume":"27","author":"Neubert","year":"2004","journal-title":"Drug Saf"},{"issue":"1","key":"yoi200053r41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.0306-5251.2001.01407.x","article-title":"Incidence of adverse drug reactions in paediatric in\/out-patients: a systematic review and meta-analysis of prospective studies.","volume":"52","author":"Impicciatore","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"yoi200053r42","first-page":"262","article-title":"Developmental pharmacokinetics in pediatric populations.","volume":"19","author":"Lu","year":"2014","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"23","key":"yoi200053r43","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence\u2014what is it and what can it tell us?","volume":"375","author":"Sherman","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"yoi200053r44","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/pds.v25.8","article-title":"Pharmacoepidemiological safety studies in children: a systematic review.","volume":"25","author":"Osokogu","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"yoi200053r45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics.","volume":"58","author":"Schneeweiss","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"yoi200053r46","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"},{"issue":"2","key":"yoi200053r47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/eb-2014-101978","article-title":"Bupropion confirmed not to cause weight gain in a real-world clinical population.","volume":"18","author":"Patten","year":"2015","journal-title":"Evid Based Ment Health"},{"issue":"3","key":"yoi200053r48","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-4082","article-title":"Guidelines for Adolescent Depression in Primary Care (GLAD-PC): part II, treatment and ongoing management.","volume":"141","author":"Cheung","year":"2018","journal-title":"Pediatrics"},{"issue":"10047","key":"yoi200053r49","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","article-title":"Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.","volume":"388","author":"Cipriani","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"yoi200053r50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/pds.v28.2","article-title":"Development and validation of algorithms to identify newly diagnosed type 1 and type 2 diabetes in pediatric population using electronic medical records and claims data.","volume":"28","author":"Teltsch","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"yoi200053r51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/EDE.0000000000000595","article-title":"A propensity-score-based fine stratification approach for confounding adjustment when exposure is infrequent.","volume":"28","author":"Desai","year":"2017","journal-title":"Epidemiology"},{"issue":"3","key":"yoi200053r53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/pto.2006.98.issue-3","article-title":"Comparison of dynamic treatment regimes via inverse probability weighting.","volume":"98","author":"Hern\u00e1n","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"yoi200053r54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios.","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"},{"issue":"1","key":"yoi200053r55","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13063-018-2519-5","article-title":"Improved adherence adjustment in the Coronary Drug Project.","volume":"19","author":"Murray","year":"2018","journal-title":"Trials"},{"issue":"10","key":"yoi200053r56","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/jamapsychiatry.2013.2053","article-title":"Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.","volume":"70","author":"Bobo","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"yoi200053r57","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamapsychiatry.2015.2923","article-title":"Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis.","volume":"73","author":"Galling","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"yoi200053r58","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1542\/peds.108.4.1033","article-title":"Clinical practice guideline: treatment of the school-aged child with attention-deficit\/hyperactivity disorder.","volume":"108","author":"American Academy of Pediatrics Subcommittee on Attention-Deficit\/Hyperactivity Disorder and Committee on Quality Improvement","year":"2001","journal-title":"Pediatrics"},{"issue":"6","key":"yoi200053r59","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models.","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"4","key":"yoi200053r60","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"3","key":"yoi200053r61","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies.","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"issue":"7","key":"yoi200053r62","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/ijo.2014.19","article-title":"Obesity and depression in adolescence and beyond: reciprocal risks.","volume":"38","author":"Marmorstein","year":"2014","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"yoi200053r63","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1210\/js.2017-00044","article-title":"Body mass index and incident type 1 and type 2 diabetes in children and young adults: a retrospective cohort study.","volume":"1","author":"Abbasi","year":"2017","journal-title":"J Endocr Soc"},{"issue":"25","key":"yoi200053r64","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"1","key":"yoi200053r65","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/YCO.0b013e32835a4206","article-title":"Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults.","volume":"26","author":"Deuschle","year":"2013","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"yoi200053r66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1517\/14740338.5.1.157","article-title":"The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms.","volume":"5","author":"McIntyre","year":"2006","journal-title":"Expert Opin Drug Saf"},{"issue":"17","key":"yoi200053r67","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1001\/jama.2014.3201","article-title":"Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.","volume":"311","author":"Dabelea","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"yoi200053r68","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.2105\/AJPH.2013.301420","article-title":"Disparities in diabetes: the nexus of race, poverty, and place.","volume":"104","author":"Gaskin","year":"2014","journal-title":"Am J Public Health"},{"issue":"1","key":"yoi200053r69","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00125-012-2715-x","article-title":"The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study.","volume":"56","author":"Scott","year":"2013","journal-title":"Diabetologia"},{"issue":"7","key":"yoi200053r70","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2337\/dc07-2417","article-title":"Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study.","volume":"31","author":"Dabelea","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"yoi200053r71","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4088\/PCC.v03n0105","article-title":"SSRI antidepressant medications: adverse effects and tolerability.","volume":"3","author":"Ferguson","year":"2001","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"4","key":"yoi200053r72","doi-asserted-by":"crossref","DOI":"10.1542\/peds.102.4.e44","article-title":"Health care utilization by children with chronic illnesses: a comparison of Medicaid and employer-insured managed care.","volume":"102","author":"Shatin","year":"1998","journal-title":"Pediatrics"},{"issue":"1","key":"yoi200053r74","first-page":"1234","article-title":"Comparative effectiveness research using observational data: active comparators to emulate target trials with inactive comparators.","volume":"4","author":"Huitfeldt","year":"2016","journal-title":"EGEMS (Wash DC)"},{"issue":"3","key":"yoi200053r75","doi-asserted-by":"publisher","first-page":"E303","DOI":"10.1002\/oby.20048","article-title":"Influence of body mass index on the choice of therapy for depression and follow-up care.","volume":"21","author":"Boudreau","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"yoi200053r52","first-page":"553","volume-title":"Longitudinal Data Analysis.","author":"Robins","year":"2009"},{"key":"yoi200053r73","volume-title":"Methods in Observational Epidemiology","author":"Kelsey","year":"1996"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2770078\/jamapsychiatry_sun_2020_oi_200053_1608576235.54286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T20:36:55Z","timestamp":1610311015000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2770078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.2762","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}